Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Is botulinum toxin A effective for the treatment of plantar fasciitis?

Peterlein CD, Funk JF, Hölscher A, Schuh A, Placzek R.

Clin J Pain. 2012 Jul;28(6):527-33. doi: 10.1097/AJP.0b013e31823ae65a.

PMID:
22673486
[PubMed - indexed for MEDLINE]
2.

Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study.

Babcock MS, Foster L, Pasquina P, Jabbari B.

Am J Phys Med Rehabil. 2005 Sep;84(9):649-54.

PMID:
16141740
[PubMed - indexed for MEDLINE]
3.

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C; BOTOX CDH Study Group.

Headache. 2005 Apr;45(4):293-307.

PMID:
15836565
[PubMed - indexed for MEDLINE]
4.

Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.

Díaz-Llopis IV, Rodríguez-Ruíz CM, Mulet-Perry S, Mondéjar-Gómez FJ, Climent-Barberá JM, Cholbi-Llobel F.

Clin Rehabil. 2012 Jul;26(7):594-606. doi: 10.1177/0269215511426159. Epub 2011 Dec 1.

PMID:
22144721
[PubMed - indexed for MEDLINE]
5.

Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study.

Boon AJ, Smith J, Dahm DL, Sorenson EJ, Larson DR, Fitz-Gibbon PD, Dykstra DD, Singh JA.

PM R. 2010 Apr;2(4):268-76. doi: 10.1016/j.pmrj.2010.02.011.

PMID:
20430328
[PubMed - indexed for MEDLINE]
6.

Botulinum toxin type A in chronic plantar fasciitis: clinical effects one year after injection.

Díaz-Llopis IV, Gómez-Gallego D, Mondéjar-Gómez FJ, López-García A, Climent-Barberá JM, Rodríguez-Ruiz CM.

Clin Rehabil. 2013 Aug;27(8):681-5. doi: 10.1177/0269215512469217. Epub 2013 Feb 14.

PMID:
23411793
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.

Göbel H, Heinze A, Reichel G, Hefter H, Benecke R; Dysport myofascial pain study group.

Pain. 2006 Nov;125(1-2):82-8. Epub 2006 Jun 5.

PMID:
16750294
[PubMed - indexed for MEDLINE]
8.

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.

Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD; BOTOX CDH Study Group.

Headache. 2005 Apr;45(4):315-24.

PMID:
15836567
[PubMed - indexed for MEDLINE]
9.

Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?

Benecke R, Heinze A, Reichel G, Hefter H, Göbel H; Dysport myofascial pain study group.

Pain Med. 2011 Nov;12(11):1607-14. doi: 10.1111/j.1526-4637.2011.01163.x. Epub 2011 Jun 21.

PMID:
21692970
[PubMed - indexed for MEDLINE]
10.

Ultrasonographic guided botulinum toxin type A treatment for plantar fasciitis: an outcome-based investigation for treating pain and gait changes.

Huang YC, Wei SH, Wang HK, Lieu FK.

J Rehabil Med. 2010 Feb;42(2):136-40. doi: 10.2340/16501977-0491.

PMID:
20140409
[PubMed - indexed for MEDLINE]
Free Article
11.

Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study.

Wissel J, Kanovsky P, Ruzicka E, Bares M, Hortova H, Streitova H, Jech R, Roth J, Brenneis C, Müller J, Schnider P, Auff E, Richardson A, Poewe W.

J Neurol. 2001 Dec;248(12):1073-8.

PMID:
12013585
[PubMed - indexed for MEDLINE]
12.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

PMID:
20515600
[PubMed - indexed for MEDLINE]
Free Article
13.

[Treatment of chronic plantar fasciitis with botulinum toxin A--an open pilot study on 25 patients with a 14-week-follow-up].

Placzek R, Hölscher A, Deuretzbacher G, Meiss L, Perka C.

Z Orthop Ihre Grenzgeb. 2006 Jul-Aug;144(4):405-9. German.

PMID:
16941299
[PubMed - indexed for MEDLINE]
14.

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M.

Neurology. 1999 Oct 22;53(7):1439-46.

PMID:
10534248
[PubMed - indexed for MEDLINE]
15.

Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.

Pappert EJ, Germanson T; Myobloc/Neurobloc European Cervical Dystonia Study Group.

Mov Disord. 2008 Mar 15;23(4):510-7.

PMID:
18098274
[PubMed - indexed for MEDLINE]
16.

Treatment of refractory anterior knee pain using botulinum toxin type A (Dysport) injection to the distal vastus lateralis muscle: a randomised placebo controlled crossover trial.

Singer BJ, Silbert PL, Song S, Dunne JW, Singer KP.

Br J Sports Med. 2011 Jun;45(8):640-5. doi: 10.1136/bjsm.2009.069781. Epub 2010 Apr 23.

PMID:
20418523
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.

Lam K, Lau KK, So KK, Tam CK, Wu YM, Cheung G, Liang KS, Yeung KM, Lam KY, Yui S, Leung C.

J Am Med Dir Assoc. 2012 Jun;13(5):477-84. doi: 10.1016/j.jamda.2012.03.005. Epub 2012 Apr 20.

PMID:
22521630
[PubMed - indexed for MEDLINE]
18.

Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.

Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ.

Cephalalgia. 2012 Apr;32(6):443-50. doi: 10.1177/0333102412441721. Epub 2012 Apr 5.

PMID:
22492424
[PubMed - indexed for MEDLINE]
19.

Randomized, placebo-controlled, double-blind clinical trial evaluating the treatment of plantar fasciitis with an extracoporeal shockwave therapy (ESWT) device: a North American confirmatory study.

Kudo P, Dainty K, Clarfield M, Coughlin L, Lavoie P, Lebrun C.

J Orthop Res. 2006 Feb;24(2):115-23.

PMID:
16435344
[PubMed - indexed for MEDLINE]
20.

Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial.

Singh JA, Mahowald ML, Noorbaloochi S.

Transl Res. 2009 May;153(5):205-16. doi: 10.1016/j.trsl.2009.02.004. Epub 2009 Mar 13.

PMID:
19375681
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk